Jane Street’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,126
Closed -$13.9K 12411
2025
Q4
$13.9K Buy
+14,126
New +$18.6K ﹤0.01% 10789
2024
Q3
Sell
-960
Closed -$22.7K 10084
2024
Q2
$22.7K Buy
+960
New +$18.3K ﹤0.01% 9029
2023
Q3
Sell
-236
Closed -$73.4K 9073
2023
Q2
$73.4K Buy
236
+205
+661% +$51.5K ﹤0.01% 8116
2023
Q1
$8.45K Sell
31
-158
-84% -$64.8K ﹤0.01% 8758
2022
Q4
$56.1K Buy
+189
New +$64.5K ﹤0.01% 8324
2021
Q4
Sell
-16
Closed -$33K 10523
2021
Q3
$33K Sell
16
-13
-45% -$27.9K ﹤0.01% 9659
2021
Q2
$71K Buy
29
+13
+81% +$31.9K ﹤0.01% 9404
2021
Q1
$39K Sell
16
-83
-84% -$247K ﹤0.01% 8883
2020
Q4
$282K Buy
+99
New +$237K ﹤0.01% 6498
2019
Q3
Sell
-42
Closed -$117K 5492
2019
Q2
$117K Buy
+42
New +$120K ﹤0.01% 4820

Other funds holding MBIO

Jane Street's MBIO Position: Q1 2026 in Review

Jane Street sold out of Mustang Bio (MBIO) in Q1 2026, closing a stake of 14,126 shares — an estimated $13.9K sold.

Jane Street first reported a position in MBIO in Q2 2019 and held it in 10 quarters. The position peaked at $282K in Q4 2020. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.

  • Jane Street reported no remaining Mustang Bio position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 14,126 Mustang Bio shares in Q1 2026, an estimated $13.9K.
  • Jane Street first reported a position in Mustang Bio in Q2 2019 and held it in 10 quarters.
  • Jane Street's Mustang Bio position peaked at $282K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.